Abstract
BackgroundThe discovery and development of first-generation immune checkpoint inhibitors (towards PD1 and CTLA-4) reached a major milestone for cancer therapy. CD40, as a member of the TNFR superfamily, plays a...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
